Genfit
Develops drugs for the prevention and treatment of cardiometabolic and neurodegenerative diseases.
Launch date
Employees
Market cap
€188m
Enterprise valuation
€181m (Public information from Sep 2024)
Share price
$4.19 GNFT
Company register number 424341907
Loos Hauts-de-France (HQ)
Authorizing premium user...